Revised Ischemic Stroke 3
Revised Ischemic Stroke 3
Revised Ischemic Stroke 3
A Case Study
Presented to the
School of Nursing
In Partial Fulfillment of
RLE
By:
Cerezo, April
Degsi, Nobeth A.
Gagarin, Mylene
Salvador, Marjurytt
I. Introduction- insights about the disease
An ischemic stroke, formerly referred to as a cerebrovascular accident or "brain attack," is a sudden
loss of function resulting from disruption of the blood supply to a part of the brain. The term brain attack
has been used to suggest to health care practitioners and the public that a stroke is an urgent health care
issue similar to a heart attack. The only U.S. Food and Drug Administration (FDA)-approved thrombolytic
therapy has a treatment window of 3 hours after the onset of a stroke, and scientific statements have
endorsed its expanded use for up to 4.5 hours (Del Zoppo, Saver, Jauch, et al., 2009; Powers, Rabinstein,
Ackerson, et al., 2019). Although the time frame for treatment has expanded, urgency is needed on the part
of the public and health care practitioners for rapid transport of the patient to a hospital for assessment and
administration of the medication.
Prevalence:
Stroke is the second leading cause of both disability and death worldwide, with the highest
burden of the disease shared by low- and middle-income countries. In 2016, there were 13.7 million new
incident strokes globally; ≈87% of these were ischemic strokes and by conservative estimation about
10%-20% of these account for LVO. Fewer than 5% of patients with acute ischemic stroke received IVT
globally in the eligible therapeutic time window and fewer than 100,000 MTs were performed worldwide
in 2016. This highlights the large gap among eligible patients and the low utilization rates of these
advances across the globe. Multiple global initiatives are underway to investigate interventions to
improve systems of care and bridge this gap (Saini, Guada, & Yavagal, 2021).
A. Patient's profile
Client’s rights:
Age: 78 years old
Sex: Female
Status: Married
Nationality: Filipino
Religion: Roman Catholic
Address: Urbiztondo, Pangasinan
Attending Physician: K. N. Decena, M.D.
Date and time of admission: March 30, 2023 @4:45pm
Admitting diagnosis: To consider cerebrovascular disease infarct, left main coronary artery territory in
hypertensive urgency HIHSS 17
Medical diagnosis: Ischemic stroke
General data
Patient X is 78 years old, female. She is a filipino citizen who lives in Urbiztondo, Pangasinan.
She is married and a housewife. She is living in a rural area and patient x is not part of any indigenous
group.
She was brought to the hospital last March 30, 2023 by her daughter because she had been
experiencing right side body weakness with difficulty of speech. It was stated that the patient has already
had multiple hospitalizations in the past, commonly with hypertension. Vital signs are taken as follows;
temperature of 36.8 degrees celsius, heart rate of 88 beats per minute, respiratory rate of 18 counts per
minute, blood pressure of 150/100 mmHg, and lastly, oxygen saturation of 96%.
B. Present complaint:
Right sided body weakness
Family hx
Mother: Hypertension
Drug therapy
The patient was given medication for hypertension such as Losartan.
D. Developmental task
E. Physical assessment
a. Health Maintenance-Perception Pattern
Prior to hospitalization: The patient doesn’t have any vices like smoking and drinking alcohol.
She also reported that she is not taking any therapeutic drugs.
During hospitalization: The patient was diagnosed to have ischemic stroke. She was given
medications such as Losartan, Linagliptin, and Clindamycin.
b. Nutritional-Metabolic Pattern
Prior to hospitalization: The patient occasionally consumes vegetables, fruits, and fish, but she
consumes meat the majority of the time. She enjoys her typical breakfast of adobong chicken and
fish. She also eats her favorite recipes with a cup of rice for lunch and dinner. She consumes at
least 7 glasses of water per day. She also mentioned that she did not have any food allergies.
During hospitalization: The patient has lost her appetite and has difficulty eating. That's why she
only eats a tiny amount of food due to her current state.
c. Elimination Pattern
Before hospitalization: The patient mentioned that she did not have any troubles in defecating,
urinating, or perspiring. She defecates once a day usually in the morning.
During hospitalization: She was inserted with IFC and changes diapers 3 times a day. The patient
has a urine output of 1000 mL to 1500 mL per shift.
e. Sleep/Rest Pattern
g. Role-Relationship Pattern
Before hospitalization: She lives with her husband, well supported and loved by her family.
During hospitalization her daughter stays and takes care of her.
h. Sexuality-Reproductive Pattern
The patient does not have any sexual activities. She has no history of sexually transmitted disease
or any disease affecting her genitals.
7. Basilar artery
The basilar artery is a midline structure formed from the confluence of the vertebral arteries.
Terminally, the basilar artery branches to establish the right and left posterior cerebral arteries. Along its
course, the basilar artery gives off several branches.
The basilar artery contributes to the posterior component of the circle of Willis and supplies the
contents of the posterior cranial fossa. It arises from the confluence of two vertebral arteries at the
medullo-pontine junction, to ascend through the basilar sulcus on the ventral aspect of the pons. It
provides arterial supply to the brainstem, cerebellum, and contributes to the posterior circulation through
the posterior cerebral arteries.
Basilar artery thrombosis refers to a cerebrovascular accident or stroke due to occlusion of the
basilar artery by a thrombus. The risk factors are similar to those in other occlusive cerebrovascular
accidents. Implicated risks include atherosclerosis promoting factors like hypertension, hyperlipidemia,
smoking, obesity, diabetes, and coronary artery disease. Clinical manifestations often correspond to the
level and degree of occlusion. Symptoms can include hemiparesis, quadriparesis, ataxia, dysphonia,
dysarthria, oculomotor palsy, and abducens palsy. These may present as groups of signs and symptoms
recognized as distinct clinical syndromes:
- "Top-of-the-basilar" syndrome involves occlusion in the rostral part of the basilar artery,
resulting in ischemia affecting the upper brainstem and the thalamus. Clinical
manifestations include behavioral changes, hallucinations, somnolence, visual changes,
and oculomotor disturbances.
- Locked-in syndrome involves occlusion at the proximal and middle part of the basilar
artery, sparing the tegmentum of the pons. The patient is thus conscious and oculomotor
function is preserved, but other voluntary muscles of the body are affected. These
patients cannot move or talk, but consciousness is evident because of vertical eye
movement, which is an oculomotor nerve function.
- Pontine warning syndrome is a basilar artery atherosclerotic disease characterized by
motor and speech disturbances that occur in a waxing and waning manner. These patients
typically experience recurrent on-and-off attacks of hemiparesis and dysarthria. This
syndrome is indicative of an imminent basilar artery branch occlusion with infarction of
the supplied region.
8. Vertebral artery
The vertebral artery is a major artery in the neck. It branches from the subclavian artery, where it
arises from the posterosuperior portion of the subclavian artery. It ascends through the foramina of the
transverse processes of the cervical vertebrae, usually starting at C6 but entering as high as C4. It winds
behind the superior articular process of the atlas. It enters the cranium through the foramen magnum
where it unites with the opposite vertebral artery to form the basilar artery (at the lower border of the
pons). The vertebral artery can be divided into four divisions:
- The first division runs posterocranial between the longus colli and the scalenus anterior.
The first division is also called the ‘pre-foraminal division’.
- The second division runs cranial through the foramina in the cervical transverse processes
of the cervical vertebrae C2. The second division is also called the foraminal division.
- The third division is defined as the part that rises from C2. It rises from the latter foramen
on the medial side of the rectus capitis lateralis, and curves behind the superior articular
process of the atlas. Then, it lies in the groove on the upper surface of the posterior arch
of the atlas, and enters the vertebral canal by passing beneath the posterior
atlantoöccipital membrane.
- The fourth part pierces the dura mater and inclines medial to the front of the medulla
oblongata.
It supplies 20% of blood to the brain (mainly hindbrain) along with the internal carotid artery (80%).
In older individuals, atherosclerotic changes and other vascular risk factors (e.g. hypertension, high
cholesterol, smoking, diabetes) may contribute to altered blood flow in the arteries. The vertebral and
carotid arteries are stressed primarily by rotation, extension and traction, but other movements may also
stretch the artery. As little as 20% of rotation and extension have been shown to significantly decrease
vertebral artery blood flow.
III. Pathophysiology
Concise and in-depth discussion
A. Illustration/Diagram of Pathophysiology
1. Etiology
The second most common cause of mortality worldwide is stroke. Each year, it
affects 13.7 million people and kills about 5.5 million. The prevalence of ischemic
infarctions, which account for about 87% of strokes, grew significantly between 1990 and
2016, which is attributed to lower mortality and better clinical interventions. The majority
of strokes are caused by primary (first-time) hemorrhages, with secondary (second-time)
hemorrhages accounting for between 10% and 25%. Over the period 1990–2016, the
incidence of stroke increased in low- and middle-income countries, while it decreased by
42% in high-income nations. The age of those affected, their sex, and their location have
all grown over time, according to the Global Burden of Disease Study (GBD), despite the
fact that the prevalence of stroke has declined.
Age-specific stroke:Age-related increases in stroke frequency double after age 55.
However, a worrisome trend shows that between 1990 and 2016, the percentage of stroke
cases worldwide among adults aged 20 to 54 rose from 12.9% to 18.6%. Nevertheless,
throughout the same time period, age-standardized attributable death rates dropped by
36.2%. China has the highest recorded rate of stroke incidence, affecting 331-378 people
per 100,000 life years. Eastern Europe has the second-highest rate (181-218 per 100,000
life years), whereas Latin America has the lowest rate (85-100 per 100,000 life years).
Gender-specific stroke: Age has an impact on both the frequency of stroke in men and
women. Women are more likely to experience it at younger ages, but men's frequency
somewhat rises with age. Pregnancy-related variables, such as preeclampsia, the use of
contraceptives and hormonal therapy, migraine with aura, and hormone therapy all
increase the risk of stroke in women. In women over 75, atrial fibrillation 20% increases
the risk of stroke. Women are also more likely to die from a stroke. Women experience
strokes at higher rates than males, which is related to their longer life expectancies.
Women's hesitation to seek medical attention for persistent symptoms is also a serious
worry. The most frequent causes of stroke in men include myocardial infarction,
excessive alcohol use, smoking, and vascular conditions.
Geographic and racial variation: A global population-based study of the prevalence of
stroke and related risks examined demography, behavior, physical characteristics,
medical history and laboratory reports, and revealed the contribution of exposure to air
pollution and particulate matter to stroke mortality. Insufficient physical activity, poor
food habits and nicotine and alcohol consumption were considered added risks.
Differences in exposure to environmental pollutants, such as lead and cadmium, also
influenced stroke incidences across regions.
Socioeconomic variation: Stroke and socioeconomic level are strongly inversely
correlated, which can be attributed to low-income populations' insufficient access to post-
stroke care and subpar hospital infrastructure. According to a case study done in the US,
those who are well off have access to more effective stroke therapy alternatives. Low
income and no health insurance were connected in a study conducted in China to the
prevention of secondary stroke attacks. There was no difference in the administration of
thrombolysis, occupational therapy, physiotherapy, or stroke care for secondary attack
according to socioeconomic status, according to research conducted in Austria. Level of
education was connected with the uptake of therapies such as echocardiography and
speech therapy. Similar to this, no matter the patients' financial situation, fundamental
medical services like thrombolysis were offered in the Scottish healthcare system.
Cardioembolism
Emboli may lodge anywhere in the cerebral arterial tree.
Emboli may originate as cardiac thrombi, especially in Atrial fibrillation, Rheumatic
heart disease (usually mitral stenosis), Post–myocardial infarction, Vegetations on heart
valves in bacterial or marantic endocarditis, Prosthetic heart valves and Mechanical
circulatory assist devices (eg, left ventricular assist device, or LVAD).
Other sources include clots that form after open-heart surgery and atheromas in neck
arteries or in the aortic arch. Rarely, emboli consist of fat (from fractured long bones), air
(in decompression sickness), or venous clots that pass from the right to the left side of the
heart through a patent foramen ovale with shunt (paradoxical emboli). Emboli may
dislodge spontaneously or after invasive cardiovascular procedures (eg, catheterization).
Rarely, thrombosis of the subclavian artery results in embolic stroke in the vertebral
artery or its branches.
Lacunar infarcts
Ischemic stroke can also result from lacunar infarcts. These small (≤ 1.5 cm) infarcts
result from non atherothrombotic obstruction of small, perforating arteries that supply
deep cortical structures; the usual cause is lipohyalinosis (degeneration of the media of
small arteries and replacement by lipids and collagen). Whether emboli causes lacunar
infarcts is controversial.
Lacunar infarcts tend to occur in older patients with diabetes or poorly controlled
hypertension.
Other causes of stroke include vascular inflammation secondary to disorders such as
acute or chronic meningitis, vasculitic disorders, and syphilis; dissection of intracranial
arteries or the aorta; hypercoagulability disorders (eg, antiphospholipid syndrome,
hyperhomocysteinemia); hyperviscosity disorders (eg, polycythemia, thrombocytosis,
hemoglobinopathies, plasma cell disorders); and rare disorders (eg, fibromuscular
dysplasia, moyamoya disease, Binswanger disease).
X-RAY
Interpretation:
• Probable cardiomegaly
• Atherosclerotic aorta
• Degenerative osseous changes
V. NCP
VI. Drug study
Drug study #1
• Generic name: Losartan
• Indication: To treat hypertension. And reduce the risk of stroke in patients with hypertension
• Action: It works by blocking the action of certain natural substances that tighten the blood
vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently.
• Nursing considerations:
-Regularly monitored for hypotension, renal function, and potassium levels.
-Notify physician immediately of pregnancy.
-Do not breastfeed while taking this drug.
Drug study #2
• Generic name: Omeprazole
• Indication:
o Symptomatic GERD without esophageal lesions
o Erosive esophagitis
o Pathologic Hypersecretory conditions
o Duodenal cancer
o Helicobacter pylori infection
o Short-term treatment of active benign gastric ulcer
o Frequent heartburn
o Dyspepsia
• Doses/route/frequency: 40 mg TIV OD
• Contraindications:
• Contraindicated in patients hypersensitive to drug or its components and in patients receiving
rilpivirine-containing products.
Alert: High-dose, long-term PPI therapy may be associated with an increased risk of hip, wrist,
and spine fractures.
Bioavailability is increased in patients of Asian descent, and reduced doses are recommended
when used for healing EE.
• Use cautiously in patients with hypokalemia and respiratory alkalosis and in patients on a low-
sodium diet.
• Risk of fundic gland polyps increases with long-term use, especially beyond 1 year.
• Long-term administration of bicarbonate with calcium or milk can cause milk-alkali syndrome.
Dialyzable drug: Unlikely.
Overdose S&S: Confusion, drowsiness, blurred vision, tachycardia, nausea, vomiting,
diaphoresis, flushing, headache, dry mouth
• Action:
Inhibits proton pump activity by binding to hydrogen–potassium adenosine triphosphatase,
located at the secretory surface of gastric parietal cells, to suppress gastric acid secretion.
Route Onset Peak Duration PO 1 hr 30 min–2 hr.
Half-life: 30 to 60 minutes.
• Major side effects:
-CNS: asthenia, dizziness, headache. GI: abdominal pain, constipation, diarrhea, flatulence,
nausea, vomiting, acid regurgitation. Musculoskeletal: back pain, weakness. Respiratory: cough,
URI. Skin: rash.
• Nursing considerations:
-Alert: May increase risk of CDAD. Evaluate for CDAD in patients who develop diarrhea that
doesn't improve.
• False-positive results in diagnostic investigations for neuroendocrine tumors may occur due to
increased CgA level. Temporarily stop omeprazole treatment at least 14 days before assessing
CgA level and consider repeating the test if initial CgA level is high. If serial tests are performed
(e.g., for monitoring), the same commercial lab should be used for testing, as reference ranges
between tests may vary.
• Long-term therapy may cause vitamin B12 absorption problems. Assess patient for signs and
symptoms of cyanocobalamin deficiency (weakness, heart palpitations, dyspnea, paresthesia, pale
skin, smooth tongue, CNS changes, loss of appetite).
• Because risk of fundic gland polyps increases with long-term use, especially beyond 1 year, use
drugs for the shortest duration appropriate to the condition being treated.
Dosage adjustments may be necessary in Asians and patients with hepatic impairment.
• Periodically assess patients for osteoporosis.
• Monitor patients for signs and symptoms of acute interstitial nephritis.
• Discontinue drug if signs or symptoms of cutaneous lupus erythematosus or SLE develop; refer
patient to the appropriate specialist for evaluation.
• Drug increases its own bioavailability with repeated doses. Drug is unstable in gastric acid; less
drug is lost to hydrolysis because the drug increases gastric pH.
• Gastrin level rises in most patients during the first 2 weeks of therapy.
Alert: Prolonged use of PPIs may cause low magnesium levels. Monitor magnesium levels before
starting treatment and periodically thereafter.
Alert: Monitor patients for signs and symptoms of low magnesium level, such as abnormal HR or
rhythm, palpitations, muscle spasms, tremors, or seizures. In children, an abnormal HR may
present as fatigue, upset stomach, dizziness, and light-headedness. Magnesium supplementation
or drug discontinuation may be required.
• Look alike–sound alike: Don't confuse Prilosec OTC with Plendil, Prevacid, prednisone, Pristiq,
Prozac, prilocaine, or Prinivil. Don't confuse omeprazole with aripiprazole, esomeprazole, or
fomepizole.
Drug study #3
• Generic name: Nicardipine Hydrochloride
• Brand name: Cardene, Cardene IV, Cardene SR
• Classification: Calcium channel blocker
• Indication: Chronic stable angina, given alone or with beta-adrenergic blockers. Hypertension
given alone or with other antihypertensives. Short-term treatment of hypertension when oral
therapy isn’t feasible or desirable.
• Doses/route/frequency:
20-40 mg P.O. (immediate release) t.i.d. wait at least 3 days before increasing release
0.5 mg/hour (equal to 20 mg P.O. q8 hours) for continuous IV infusion
• Contraindications:
-Hypersensitivity to drug
-Advanced aortic stenosis
• Action: Inhibits calcium transport into myocardial and vascular smooth muscle cells, causing
cardiac output and myocardial contractions to decrease.
• Major side effects:
CNS: dizziness, headache, asthenia, drowsiness, paresthesia
CV: hypotension, peripheral edema, chest pain, increased angina, palpitations
GI: nausea, dyspepsia, dry mouth
Musculoskeletal: myalgia
Skin: flushing
• Nursing considerations:
• Closely monitor BP and HR. Drug can cause symptomatic hypotension or tachycardia.
Measure Bp frequently during initial therapy. Maximal response occurs in about 1 hour.
Check for orthostatic hypotension. Because large swings in BP may occur based on drug
level, assess hypertensive effect 8 hours after dosing.
• Alert: Only immediate-release drug for is approved for treatment of angina.
To reduce the risk of venous thrombosis, phlebitis, and vascular impairment, don’t use
small veins such as those on the dorsum of the hand or wrist. Use extreme care to avoid
intra-arterial administration or extravasation.
• Look alike-sound alike: don’t confuse nicardipine with niacinamide, nifedipine, or
nimodipine. Don’t confuse Cardene with Cardura,Cardizem, or codeine.
Drug study #4
• Generic name: Metoclopramide
• Brand name:
• Regal and Metozolv ODT
• Classification:
• Prokinetic agents
• Indication:
• To prevent or reduce nausea and vomiting
• To prevent or reduce postoperative nausea and vomiting
• To facilitate small-bowel intubation
• Delayed gastric emptying secondary to diabetic gastroparesis
• Gerd
• Dose/route/frequency:
• 10mg TIV q8h, PRN for nausea and vomiting
• Contraindication:
• Contraindicated in patients hypersensitive to drug and in those with pheochromocytoma.
• Contraindicated in patients for whom stimulation of GI motility might be dangerous.
• Action:
• Stimulates motility of upper GI tract, increases lower esophageal sphincter tone, and
blocks dopamine receptors at the chemoreceptor trigger zone.
• Major side effect:
• Drowsiness
• Excessive tiredness
• Weakness
• Headache
• Dizziness
• Diarrhea
• Nausea
• Vomiting
• Frequent urination
• Inability to control urination
• Nursing considerations:
• Monitor bowel sounds
• Safety and effectiveness of drug haven’t been established for therapy lasting longer than
12 weeks.
• Monitor patient for involuntary movements of face, tongue, and extremities.
• Monitor patient for fever, CNS symptoms, irregular pulse, cardiac arrhythmias, or
abnormal BP.
• Monitor patient for dizziness, headache, or nervousness after metoclopramide is stopped.
Drug study #5
• Generic name: Paracetamol
• Classification: Analgesic/antipyretic
• Action: Paracetamol has a central analgesic effect that is mediated through activation of
descending serotonergic pathways. Debate exists about its primary site of action, which may be
inhibition of prostaglandin (PG) synthesis or through an active metabolite influencing
cannabinoid receptors.
• Nursing considerations:
Drug study #6
• Generic name: Diazepam
• Brand name: Diastat
• Contraindications:
-Documented hypersensitivity
-Acute alcohol intoxication
-Myasthenia gravis (allowable in limited circumstances)
-Acute narrow-angle glaucoma and open-angle glaucoma unless patients receiving appropriate
therapy
-Severe respiratory depression
-Intravenous (IV) use in shock, coma, depressed respiration, patients who recently received other
respiratory depressants
-Sleep apnea
-Children under 6 months
• Nursing considerations:
Drug study #7
• Doses/route/frequency: 50 mg PO BID
• Major side effects: Bradycardia, tachycardia, Diplopia, epigastric distress, stomach pain, malaise,
Anorexia, Insomnia, Headache, Diarrhea
• Nursing considerations:
-Monitor for adverse effect; instruct the patient to report immediately if she develops chest
tightness, tingling in mouth and throat, headache, diarrhea, and blurring vision.
-Citicoline may be taken with or without food. Take it with or between meals.
-The supplement should not be taken in the late afternoon or at night because it can cause
difficulty sleeping.
Drug Study #8
• Indication: Adjunct to diet for controlling LDL, total cholesterol, apo-lipoprotein B, and
triglyceride levels and to increase HDL levels in patients with primary hypercholesterolemia and
mixed dyslipidemia; primary dysbetalipoproteinemia in patients unresponsive to diet alone;
adjunct to diet to reduce elevated triglyceride levels.
• Doses/route/frequency: 40 mg PO OD
• Contraindications:
-Pregnancy or breastfeeding
• Action: Inhibits HMG- CoA reductase, which catalyzes first step in cholesterol synthesizes; this
action reduces concentrations of serum cholesterol and low-density lipoproteins (LDLs), linked to
increased risk of coronary artery disease (CAD). Also moderately increases concentration of
high-density lipoproteins (HDLs), associated with decreased risk of CAD.
• Major side effects: amnesia, anemia, rectal hemorrhage, thrombocytopenia, hepatic failure, toxic
epidermal necrolysis, bursitis, amblyopia
• Nursing considerations:
-Be aware that reduction in dosage and periodic monitoring of creatine kinase level may be
considered for patients taking drugs that may considered for patients taking drugs that may increase
atorvastatin level.
Drug study #9
• Indication: Indicated for the treatment of type II diabetes in addition to diet and exercise5. It
should not be used to treat type I diabetes or in diabetic ketoacidosis.
• Action: It works by increasing the amounts of certain natural substances that lower blood sugar
when it is high.
• Nursing considerations:
-Assess the patient’s medical history and current medications.
-Monitor blood glucose levels.
-Educate the patient on proper medication use.
-Blood and urine tests may be needed to check for unwanted effects.
-Check with your doctor right away if you have a sudden and severe stomach pain, chills,
constipation, nausea, vomiting, loss of appetite, fever, or lightheadedness.
Drug study #10
• Doses/route/frequency: 30 cc ODHS PO
• Action: Chief mechanism of action is by decreasing the intestinal production and absorption of
ammonia. It has also gained popularity as a potential therapeutic agent for the management of
subacute clinical encephalopathy. It is also a laxative for the treatment of chronic constipation.
• Nursing considerations:
-Monitor blood sugar for diabetes (preparation contains lactose and galactose)
-Monitor for electrolyte imbalance when the drug is used for longer than 6 months or in patients
predisposed to electrolyte abnormalities
-Avoid using other laxatives concomitantly
-Inadequate response possible when taken concomitantly with anti-infective
-Lactulose use during pregnancy may be acceptable. Either animal studies show no risk, or
human studies are not available or animal studies showed minor risks, and human studies were
done and showed no risk
-It is unknown if lactulose is distributed into breast milk; use with caution
VII. Conclusion
The second most common cause of mortality worldwide is stroke. Each year, it affects 13.7
million people and kills about 5.5 million. The prevalence of ischemic infarctions, which account for
about 87% of strokes, grew significantly between 1990 and 2016, which is attributed to lower mortality
and better clinical interventions. The majority of strokes are caused by primary (first-time) hemorrhages,
with secondary (second-time) hemorrhages accounting for between 10% and 25%. Over the period 1990–
2016, the incidence of stroke increased in low- and middle-income countries, while it decreased by 42%
in high-income nations. Stroke is a very serious matter, it can be fatal if there is no immediate action. So
it is very important that every individual in our society know how to assess for a stroke.
REFERENCES:
McGraw-Hill Nurse’s Drug Handbook Seventh Edition
Natale, N., Petit, R., Champane, J., Rodriguez, C., Ladna, J., & Savu, C. (2021). A Rare Presentation of
Posterior Cerebral Artery Stroke With Monocular Hemianopia After Diesel Exposure. Cureus, 13(5),
e14977. https://doi.org/10.7759/cureus.14977
https://www.physio-pedia.com/home/
Charlick M, M Das J. Anatomy, Head and Neck: Internal Carotid Arteries. [Updated 2022 Jul 25]. In:
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK556061/
Adigun OO, Reddy V, Sevensma KE. Anatomy, Head and Neck: Basilar Artery. [Updated 2022 Aug 8].
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK459137/
Ali F, Reddy V, Dublin AB. Anatomy, Back, Anterior Spinal Artery. [Updated 2022 Jul 25]. In:
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK532963/
Saini, V., Guada, L., & Yavagal, D. R. (2021). Global Epidemiology of Stroke and Access to Acute
Ischemic Stroke Interventions. Neurology, 97(20 Suppl 2), S6–S16.
https://doi.org/10.1212/WNL.0000000000012781